Connect with us

Technology

New Report from Clarivate and Healthcare Executive Explores Mainland China’s Biopharma Revolution and Increasing Global Influence

Published

on

New report analyses Mainland China’s transformation into a global biopharma powerhouse, with key insights for international stakeholders

LONDON, Nov. 18, 2024 /CNW/ — Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, in partnership with Healthcare Executive, published by the China Pharmaceutical Enterprises Association, today announced the release of a new report, A Decade of Innovation, A Decade to Come.

Over the past decade, Mainland China’s biopharmaceutical sector has rapidly advanced to become a global leader in innovation, ranking among the top three for initial drug launches. Driven by reforms, increased investment, and progressive policies, the industry has reduced approval timelines, raised regulatory standards, and improved patient access to advanced therapies. Insights from the Institute for Scientific Information™ show that China’s Gross Expenditure on Research and Development has grown 3.5 times over the past decade, outpacing growth rates in the UK and the U.S.1 These developments, combined with an evolving healthcare reimbursement system, have enabled both domestic and multinational companies to bring new therapies to market, benefiting millions of patients.

Henry Levy, President, Life Sciences & Healthcare, Clarivate, said: “Mainland China’s ascent in the biopharma sector reflects the power of sustained investment and strategic reform. This report not only highlights the impressive achievements of the past decade but also underlines the far-reaching potential for Chinese biopharma companies to drive global medical innovation and enhance patient outcomes worldwide.”

Tan Yong, Vice President of China Pharmaceutical Enterprises Association and Publisher of Healthcare Executive, noted: “The pharmaceutical industry is poised for significant and transformative changes in the upcoming decade, driven by heightened competition. Rapid innovation and intense competition have reshaped market dynamics, leading to more focused and sustainable growth. The report offers the industry a glimpse of how Chinese pharmaceutical companies can prioritize innovation and international expansion in the next decade.”

Alice Zeng, Senior Solution Consultant, Life Sciences & Healthcare, Clarivate, added: “This report is an invaluable resource for global industry stakeholders. For pharma companies worldwide, it provides a timely understanding of Mainland China’s biopharma landscape, covering the opportunities for international collaboration and the potential for accelerated market entry.”

The report highlights Mainland China’s regulatory advancements, rapid drug launch growth, and expanding domestic R&D role. Key updates include the National Reimbursement Drug List (NRDL), where systematic price negotiations have cut costs by 50-60%, improving access to innovative drugs. Additionally, Mainland China’s share of global licensing and service deals has grown from 6.5% to nearly 9% since 2015, and the country now leads in publishing research and filing patents in key life sciences, underscoring its rising influence on the global industry.

Key insights in A Decade of Innovation, A Decade to Come, include:

Impactful policy reforms: How regulatory initiatives such as the Marketing Authorization Holder (MAH) system and priority review programs have streamlined approvals and bolstered R&D.Healthcare accessibility and innovation: An examination of Mainland China’s healthcare reforms, including the expansion of the NRDL and commercial health insurance, increasing access to cutting-edge therapies.Investment and R&D growth: Analysis of Mainland China’s record-breaking R&D investment, driving advancements in oncology, anti-infectives, and emerging therapeutic areas.Global Integration and market opportunities: Insights into the rise of Mainland China’s biopharma sector as a global player, including the increase in multinational collaborations and first-to-market launches.

With Mainland China’s share of first-time global drug launches growing, and as new therapeutic areas advance, A Decade of Innovation, A Decade to Come provides timely, in-depth insights for international investors, multinational pharmaceutical companies, and healthcare stakeholders who seek to understand Mainland China’s role in shaping the future of the biopharma landscape.

The A Decade of Innovation, A Decade to Come report draws on comprehensive data and tools trusted by the global life sciences community, including Cortellis Competitive Intelligence, Cortellis Regulatory Intelligence™, Disease Landscape & Forecast, Cortellis Deals Intelligence, Cortellis Clinical Trials Intelligence™, Cortellis Product Intelligence™, Real World Data and Analytics, Access and reimbursement payer studies, BioWorld™, Web of Science™ and Derwent Innovation™ among others. Compiled by Clarivate analysts using data gathered prior to August 31, 2024, this report reflects Clarivate’s commitment to supporting drug, device, and medical technology lifecycles. By combining patient journey data, therapeutic insights, and AI-driven analytics, Clarivate enables evidence-based decisions that advance human health.

To learn more about the Clarivate report, A Decade of Innovation, A Decade to Come, visit here.

About Healthcare Executive
With media as the outpost, conference as the platform, live video broadcasting as the tool, and expert pharmaceutical industry observers and recorders as the living force, Healthcare Executive (E药经理人) brings the top consensus of entrepreneurs, scientists, and investors in the pharmaceutical industry together on the one hand, and on the other hand gathers multi-dimensional and multi-level resources from the whole industry chain. We are dedicated to providing in-depth professional communication opportunities and influential solutions for the whole industry chain in their whole life cycle. In this regard, we make connections with client requirements upstream and downstream and make preparations for the overseas strategy in their international programs.

About Clarivate
Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com

Media Contact 
Catherine Daniel
Director, External Communications, Life Sciences & Healthcare
Clarivate
newsroom@clarivate.com

1 Source: Global Research Report: China’s research landscape, ISI, Clarivate

View original content to download multimedia:https://www.prnewswire.com/news-releases/new-report-from-clarivate-and-healthcare-executive-explores-mainland-chinas-biopharma-revolution-and-increasing-global-influence-302307317.html

SOURCE Clarivate Plc

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Trustpilot wins landmark legal case against review sellers ahead of new law banning the sale of fake reviews

Published

on

By

LONDON, Nov. 18, 2024 /PRNewswire/ — Trustpilot, the global online consumer review platform, has won a landmark legal case in the UK against a series of websites that were selling hundreds of fake reviews.

The High Court agreed the review sellers – TPR, SMM Service Buy and SMM 420, were unlawfully inducing businesses who use the platform to breach its terms of use, passing off fake reviews as authorised by Trustpilot and infringing its trademarks.

Following the ruling, Trustpilot is calling on internet service providers and payment providers to take down the websites identified in the legal action.     

The ruling comes as the Competition and Markets Authority prepares to enforce a new law banning the practice of buying or procuring fake reviews. The Digital Markets, Competition and Consumers Act comes into force in April 2025, which will allow the CMA to take action against businesses who break the rules.

Anoop Joshi, Trustpilot’s Chief Trust Officer said: “This is a significant moment in the fight against websites that sell fake reviews, and we want to send a clear message that we will not tolerate review seller activity on Trustpilot. We decided to take action now, ahead of the UK law being introduced, because we’re determined to root out and take action against businesses or individuals who could pose a threat to the integrity of our platform. Ensuring businesses and consumers are able to access genuine reviews on Trustpilot is essential to safeguarding the services we provide”.

Over the past 2 years Trustpilot has successfully brought 10 legal cases against businesses who continually abused the platform’s rules to manipulate others through online reviews. In 2023 Trustpilot removed 3.3 million fake reviews from the platform. The removal rate remains consistent at 6% of the total amount of reviews received year on year. 

About Trustpilot

Trustpilot began in 2007 with a simple yet powerful idea that is more relevant today than ever – to be the universal symbol of trust, bringing consumers and businesses together through reviews. Trustpilot is open, independent, and impartial – we help consumers make the right choices and businesses to build trust, grow and improve.

Today, we have more than 300 million reviews on the platform and 57 million monthly active users across the globe, with 117 billion annual Trustpilot brand impressions, and the numbers keep growing. We have more than 900 employees and we’re headquartered in Copenhagen, with operations in Amsterdam, Denver, Edinburgh, Hamburg, London, Melbourne, Milan and New York. 

For more information, please visit www.trustpilot.com

Logo – https://mma.prnewswire.com/media/2236459/4317181/Trustpilot_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/trustpilot-wins-landmark-legal-case-against-review-sellers-ahead-of-new-law-banning-the-sale-of-fake-reviews-302308376.html

Continue Reading

Technology

/R E P E A T — MEDIA ADVISORY – Media tour of Centre Block construction site/

Published

on

By

GATINEAU, QC, Nov. 15, 2024 /CNW/ – Members of the specialized media are invited to follow a guided tour of the Centre Block construction site on Tuesday, November 19. Representatives from Public Services and Procurement Canada and Parliamentary Administrations will provide the tour and answer questions.

Please note that all details are subject to change. All times are local.

Date: Tuesday, November 19, 2024

Bilingual Tour : meeting time 8:45 a.m.

Meeting point: Centennial Flame, Parliament Hill 

Duration: Approximately 3 hours, including the health and safety briefing

Please note that space is limited. To register, please contact Media Relations by email no later than Monday, November 18 at 2:00 p.m.

IMPORTANT INFORMATION

Please be aware that the tour will take place in an active construction site. A mandatory health and safety briefing will be provided and protective equipment (boots, hard hat, glasses, gloves and vest) will be distributed on-site before the tour. Long pants are required and tank tops are not allowed for health and safety reasons. Please note:  boot sizes are required in advance and should be provided upon registration.

For security reasons, photography and video will be restricted in certain areas.

Follow us on X (Twitter)
Follow us on Facebook

SOURCE Public Services and Procurement Canada

Continue Reading

Technology

Dispersive Appoints Cybersecurity Visionary Lawrence Pingree as Vice President – Technical Marketing

Published

on

By

Veteran Cybersecurity Leader to Spearhead Strategic Marketing and Strengthen Dispersive’s Stealth Networking Solutions Amid Evolving Cyber Threats

ROSWELL, Ga., Nov. 18, 2024 /PRNewswire/ — Dispersive, an innovative leader in Stealth Networking technology, is proud to announce the appointment of Lawrence Pingree as Vice President – Technical Marketing. Pingree, a seasoned cybersecurity executive with a distinguished track record at Gartner and across the industry, will play a pivotal role in propelling Dispersive’s mission to redefine secure communications and bolster global cybersecurity resilience.

A Proven Leader in Cybersecurity

With nearly 30 years of impactful experience, Lawrence Pingree has cemented his reputation as a thought leader and influential figure in the cybersecurity field. During his tenure at Gartner, Pingree held multiple executive positions, including Vice President Emerging Technologies and Trends – Cloud and Endpoint Security, Managing Vice President of Emerging Technologies – Security & Risk, and Research Vice President – Security Technologies. His strategic oversight and visionary research significantly shaped the understanding and evolution of critical cybersecurity technology.

Pingree’s contributions include publishing over 300 influential research notes, introducing groundbreaking concepts such as Security as a Service (SaaS), Software-Defined WAN (SD-WAN), Endpoint Detection and Response (EDR), Threat Intelligence Platforms (TIP), Threat Intelligence Gateways (TIG) and Secure Internet Gateways (SIG). His work provided key strategic and tactical guidance to technology providers and end-users alike, empowering them to navigate an increasingly complex threat landscape.

In addition to his corporate roles, Pingree’s professional affiliations have included serving as Vice President of the Digital Forensics Association, being an active member of the Silicon Valley chapter of the Information Systems Security Association (ISSA) and contributing to the Open Web Application Security Project (OWASP). These roles underscore his commitment to advancing cybersecurity knowledge and practice at both organizational and community levels.

Joining Forces with Dispersive

“Joining Dispersive is an opportunity to align my passion for cybersecurity with a company that embodies true innovation in secure networking,” said Pingree. “Dispersive’s approach to preemptive, quantum-resistant cybersecurity uniquely positions it to address the urgent and evolving needs of our hyperconnected world. I am excited to contribute to the company’s mission to safeguard global communications through cutting-edge, adaptable solutions.”

Dispersive’s Stealth Networking solutions leverage military-grade tactics to ensure data in transit is secure and protected against advanced threats, including nation-state actors and complex supply chain attacks. By constructing virtual, active/active multipath mesh networks with rolling encryption keys and granular access controls, Dispersive offers unmatched security, resilience, and performance. The software-only solution can be globally deployed in minutes, requiring minimal operational overhead and seamlessly integrating with existing infrastructure.

“With Lawrence’s deep expertise and leadership, Dispersive is positioned to not only reinforce our technological innovation but also scale our customer and market impact,” said Rajiv Pimplaskar, CEO of Dispersive. “His proven ability to introduce and drive new ideas and technologies makes him ideal to drive our strategic marketing initiatives and help safeguard our critical infrastructure customers.”

About Dispersive

Dispersive is a pioneering provider of secure networking software, focused on preemptive cybersecurity and Stealth Networking. Inspired by military strategies, Dispersive’s technology ensures unmatched data security, obfuscation, and network performance. With solutions like DispersiveCloud and DispersiveFabric, the company empowers organizations to operate securely and confidently in an environment where cybersecurity threats driven by hyperconnectivity, generative AI, and quantum computing are at an all-time high. For more information on Dispersive and its innovative approach to cybersecurity, visit www.dispersive.io.

Media Contact:
Amy Levine
Director of Marketing
Dispersive
844.403.5850
alevine@dispersive.io
www.dispersive.io

View original content to download multimedia:https://www.prnewswire.com/news-releases/dispersive-appoints-cybersecurity-visionary-lawrence-pingree-as-vice-president—technical-marketing-302306656.html

SOURCE Dispersive Holdings, Inc.

Continue Reading

Trending